Clinical Trials Directory

Trials / Unknown

UnknownNCT03494673

Prediction of WMH in Migraine Using a BOLD-CVR Map

Research of Brain White Matter Hyperintensity in Migraine Using a Cerebrovascular Reactivity Mapping Based on BOLD MRI

Status
Unknown
Phase
Study type
Observational
Enrollment
74 (actual)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Brain white matter hyperintensities (WMHs) are prevalent in migraineurs, of which the mechanism is still unclear. The investigators aimed to test the spatial association between areas with reduced cerebrovascular reactivity (CVR) to hypercapnic stimuli and consequent development of WMHs.

Detailed description

A whole-brain map of CVR will be created in patients with migraine and normal controls. Hypercapnic stimuli for CVR will be delivered by prospective end-tidal CO2 targeting device. Hemodynamic responses will be determined by BOLD signal changes using fMRI. WMHs will be determined by high-resolution 3D FLAIR imaging. Patients and controls will undergo serial MRIs with 1 year interval. Associations between areas of reduced CVR and consequent WMH development will be tested in both patients and controls.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBOLD MRI1. Prospective End-tidal targeting RespirAct device(A specially designed gas blender and sequential rebreathing circuit) will be used to implement the gas targeting method which involves precise elevations in End-tidal PCO2 while maintaining a fixed End-tidal PO2 2. BOLD MR images will be obtained by using a T2\*-weighted two-dimensional gradient-echo sequence with echoplanar readout.

Timeline

Start date
2018-07-13
Primary completion
2020-02-28
Completion
2020-02-28
First posted
2018-04-11
Last updated
2019-04-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03494673. Inclusion in this directory is not an endorsement.